COMMUNIQUÉS West-GlobeNewswire

One-Year Follow-Up Shows 71.4% Progression-Free Survival in 14 Prostate Cancer Patients Treated with ProscaVax in Phase 1 Clinical Trial

21/12/2017 - 17:26

BATON ROUGE, La., Dec. 21, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of a proprietary [...]

ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock

21/12/2017 - 17:00

PORTLAND, Maine, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (“ImmuCell” or the “Company”) (Nasdaq: ICCC ), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLetTM

21/12/2017 - 15:47

Company announcement - No. 56/2017 Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLet TM Zealand Pharma makes an initial USD 1.5 million equity investment in the [...]

The Financial Calendar of JSC “Grindeks” for the year of 2018

21/12/2017 - 15:22

JSC "Grindeks" plans to publish its: non-audited interim financial statement for the 12-month period of 2017 on 28 February 2018; non-audited interim financial statement for the 3-month period of 2018 on 31 May 2018; [...]

HMS Teams with Halfpenny Technologies to Strengthen Payer-Provider Collaboration, Promoting Seamless Care Management

21/12/2017 - 15:11

IRVING, Texas, Dec. 21, 2017 (GLOBE NEWSWIRE) -- HMS , a leading provider of cost containment and health management solutions to the U.S. healthcare market, today announced the launch of a strategic partnership with [...]

NSS Labs Announces Industry’s First Data Center Security Gateway Group Test Results

21/12/2017 - 15:00

Five Products Receive Recommended Rating for IPv4; Four Products Receive Recommended Rating for IPv6 AUSTIN, Texas, Dec. 21, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, [...]

NewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 15:00

AMES, Iowa, Dec. 21, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today that the company will present at the 36 th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, [...]

Chembio Diagnostics Announces Completion of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System

21/12/2017 - 14:50

MEDFORD, N.Y., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced completion of the U.S. clinical trial [...]

Agritek Holdings, Inc. Announces New Feature Interview And Update As Public Cannabis Company On Fox Business Network First Week Of January 2018

21/12/2017 - 14:30

LOS ANGELES, CA, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis [...]

Avinger Announces 510(k) Filing of Next Generation Pantheris Device

21/12/2017 - 14:30

REDWOOD CITY, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced the Company submitted a new 510(k) [...]

Articles of Association for Genmab A/S

21/12/2017 - 14:27

Genmab A/S has published its Articles of Association dated December 15, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis Gravesen, Senior Vice [...]

aTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium

21/12/2017 - 14:00

SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering [...]

CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board

21/12/2017 - 14:00

ZUG, Switzerland and CAMBRIDGE, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ) today announced the appointment of Dr. Rodger Novak, founder and former CEO of CRISPR Therapeutics as Chairman [...]

Emblem Corp. and Dosecann Inc. Sign Licensing Deal to Develop Dosage-Controlled Formulations

21/12/2017 - 14:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSX-V: EMC ) (EMC.WT) (“Emblem” or the “Company”) , has entered [...]

BioSig Technologies Issues Shareholder Letter for 2017

21/12/2017 - 14:00

Santa Monica, CA, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Altimmune Announces Positive Initial Data from Its HepTcell Phase 1 Study

21/12/2017 - 14:00

HepTcell well tolerated in all cohorts Initial data on secondary endpoint demonstrates T cell responses GAITHERSBURG, Md., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage [...]

AMAG Pharmaceuticals Awards $300,000 in Grants to Further Research in Preterm Birth and Neonatal Health

21/12/2017 - 14:00

WALTHAM, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- As part of the company’s ongoing support of maternal and neonatal health, AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced it has awarded four grants totaling [...]

Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial Comparing Seltorexant (MIN-202) Versus Quetiapine as Adjunctive Therapy to Antidepressants in Patients With Major Depressive Disorder

21/12/2017 - 14:00

WALTHAM, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

PolarityTE to Participate in Corporate Access Event in San Francisco, January 8 – 9, 2018

21/12/2017 - 14:00

SALT LAKE CITY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ) today announced that its senior management team will host institutional investor and partnering meetings at the LifeSci Advisors [...]